Crossmark

Abnormally high plasma concentrations of M-4, the active metabolite of edoxaban, at the onset of acute kidney injury in a patient receiving rifampin and clarithromycin: a case report

Crossref DOI link: https://doi.org/10.1186/s40780-024-00390-6

Published Online: 2024-10-28

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Nakagawa, Junichi

Ishido, Keinosuke

Kimura, Norihisa

Nagase, Hayato

Wakasa, Yusuke

Yokoyama, Satoshi

Ueno, Kayo

Hakamada, Kenichi

Niioka, Takenori https://orcid.org/0000-0002-4560-6423
License Information

Text and Data Mining valid from 2024-10-28

Version of Record valid from 2024-10-28
More Information

Article History

Received: 23 August 2024

Accepted: 23 October 2024

First Online: 28 October 2024

Declarations

:

: Written informed consent was obtained from this patient for the measurement of each biomarker and polymorphisms of pharmacokinetics-related genes.

: Informed consent to publish was obtained from the patient presented in this article.

: Dr Niioka received speakers’ honoraria from Daiichi-Sankyo. The remaining authors have nothing to disclose.

Document is current

Any future updates will be listed below